COVID-19 and Diabetes; possible role of polymorphism and rise of telemedicine

The pandemic corona virus disease 2019 (COVID-19) which originated from Wuhan, China is caused by a single-stranded, positive-sense RNA genome containing enveloped virus [1,2]. Till 6th August 2020, globally 18614177 people have been infected with an unprecedented mortality of 702642 [3]. Diabetes, one of the biggest leading cause of death world-wide with a 463 million patient burden, is a metabolic disorder caused by insulin de ficiency and/or insulin resistance characterized by hyperglycemia, polyphagia and polydipsia [4,5].

Source: Primary Care Diabetes - August 30, 2020 Category: Primary Care Authors: Shomoita Sayed Tags: Review Source Type: research